AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metgli V 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Ordain Health Care Global Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Metgli V 2mg/500mg/0.2mg Tablet

Diabetic patients (adults) utilize Metgli V 2 mg/500 mg/0.2 mg tablets, an antidiabetic medication combination, to manage type 2 diabetes mellitus. This medication regulates blood glucose, administered with meals at a consistent daily time for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as advised by your healthcare provider. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (sugary foods/juice) is essential upon experiencing these symptoms. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Pre-existing heart conditions necessitate physician consultation before commencing treatment. Pregnant or lactating individuals require medical guidance. Regular blood glucose monitoring, along with blood cell and liver function tests, are recommended by your physician.

Primary Ingredients of Metgli V 2mg/500mg/0.2mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Metgli V 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Metgli V 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Metgli V 2 mg/500 mg/0.2 mg tablets on an empty stomach.

Common Side effects of Metgli V 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Metgli V 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 2 mg/500 mg/0.2 mg Metgli V tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.

How Metgli V 2mg/500mg/0.2mg Tablet works:

Each Metgli V tablet (2 mg/500 mg/0.2 mg) contains a triple-action blend of antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Metgli V 2 mg/500 mg/0.2 mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metgli V 2 mg/500 mg/0.2 mg Tablet during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metgli V 2 mg/500 mg/0.2 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such conditions arise.

KidneyKidneyUNSAFE

Employing Metgli V 2 mg/500 mg/0.2 mg tablets in individuals with kidney disease carries a significant risk and is best avoided. Medical advice should be sought. Furthermore, this medication is contraindicated for patients exhibiting severe kidney impairment.

LiverLiverCAUTION

Individuals with liver impairment should use Metgli V 2 mg/500 mg/0.2 mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metgli V 2mg/500mg/0.2mg Tablet :

Should you forget to take your Metgli V 2 mg/500 mg/0.2 mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Metgli V 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metgli V 2mg/500mg/0.2mg Tablet

Metgli V 2 mg/500 mg/0.2 mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Metgli V 2 mg/500 mg/0.2 mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Metgli V 2 mg/500 mg/0.2 mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Metgli V 2 mg/500 mg/0.2 mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metgli V 2 mg/500 mg/0.2 mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Metgli V 2mg/500mg/0.2mg ...
95
MRP 110
13% off